Skip to main content
. 2019 Mar 7;52(3):e12592. doi: 10.1111/cpr.12592

Figure 2.

Figure 2

The Wnt signalling pathway is involved in Rab25‐mediated erlotinib resistance. (A, B) Western blotting showing key molecules of the Wnt signalling pathway in the indicated cells. (C) Cell proliferation in the indicated cells was measured by an EdU assay. (D) Propidium iodide staining detected cell cycling in the indicated cells, and ModFit was used to analyse the S phase ratio of the cells. **P < 0.01, mean ± SEM, ANOVA. After treatment with LiCl for 24 h, the P‐GSK‐3β and β‐catenin levels were measured in the PC9/ER/shRab25 and HCC827/ER/shRab25 cells by Western blotting (E), and cell proliferation (F) and cell cycling (G) were detected in these cells.